Modifiable factors and progression of motor symptoms and cognitive decline in Parkinson’s disease
Objective: To determine the association between potentially modifiable factors including (1) cardiovascular risk factors (2) neuropsychiatric symptoms, and (3) sleep quality and progression of motor…Effect of Levodopa on gut microbiome in Parkinson’s Disease (PD)
Objective: To characterize changes in the gut microbiome in de novo PD subjects before and after initiating carbidopa/levodopa Background: The gastrointestinal microbiome in patients with…Parkinson’s disease polygenic risk score is not associated with impulse control disorders: a longitudinal study
Objective: To examine the relationship between a polygenic risk score (GRS) associated with Parkinson’s disease (PD) and impulse control disorders (ICDs) in PD. Background: Genome…No difference in balance and gait parameters of the patients with akinetic-rigid and tremor-dominant Parkinson’s disease
Objective: To compare balance and gait parameters between subtypes of Parkinson's disease (PD). Background: PD, which is a progressive neurodegenerative disease, has different clinical courses…Serum uric acid level as a biomarker in sporadic and familial (p.A53T alpha synuclein carriers) Parkinson’s disease: Longitudinal data from the PPMI study
Objective: To determine whether there are longitudinal differences in serum uric acid level among sporadic Parkinson’s disease (PD) patients, PD patients harboring the p.A53T mutation…Patients Experiencing Motor Fluctuations With Parkinson’s Disease (PD): Participant Characteristics in the Accordance Phase 3 Efficacy and Safety Trial of Accordion Pill™ Carbidopa/Levodopa
Objective: To provide baseline and clinical characteristics for participants in the phase 3 Accordance study of the Accordion Pill™ (AP)—a gastric-retentive formulation of carbidopa/levodopa (CD/LD)—versus…Repetitive transcranial magnetic stimulation can improve anxiety in Parkinson’s disease: a randomized, double-blind and controlled trial
Objective: High frequrncy (HF) repetitive transcranial magnetic stimulation (rTMS) improve anxiety in Parkinson’s Disease (PD). Background: The high frequency repetitive transcranial magnetic stimulation above the…Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease
Objective: To evaluate patient-centered outcomes after deep brain stimulation in Parkinson's disease. Background: Deep brain stimulation (DBS) is an effective treatment for Parkinson's disease (PD) patients. Long-term…Parkinsonian syndrome associated to C9orf72 expansion
Objective: To describe a case of parkinsonian syndrome associated to C9Orf72 expansion followed by ALS development Background: C9Orf72 expansions are known to be the most…Detection of impaired finger dexterity by objective keyboard typing test in Parkinson’s Disease: A feasibility study
Objective: To objectively evaluate finger dexterity in Parkinson’s disease (PD) patients by keyboard typing test. Background: Impaired motor dexterity is a type of bradykinesia which…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.